CSIMarket
 


Revance Therapeutics Inc   (RVNC)
Other Ticker:  
 


Revance Therapeutics Inc 's Pre-Tax Profit Margin by quarter

Trends, Rankings, Statistics



RVNC Pre-Tax Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 39.82 % 95.68 % 104.93 % 95.29 % 92.37 %
Seq. Revenue Change 22.94 % -2.34 % 17.84 % -1.18 % 72.05 %
Revenue In Millions $69.80 $56.78 $58.13 $49.33 $49.92
Pre-Tax Profit Margin - -1.06 % -115.8 % -121.21 % -
Pre-Tax Profit Margin Total Ranking # 27 # # # # 94
Pre-Tax Income In Millions $127.11 $-0.60 $-67.32 $-59.79 $125.78
Y / Y Pre-Tax Income Change - - - - -
Seq. Pre-Tax Income Change - - - - -


Commenting fourth Quarter 2023 Pre-Tax Profit Margin
Revance Therapeutics Inc achieved Pre-Tax Income of $127 millions compare to Pre-Tax Loss of $-0.60 millions recorded in previous quarter. Revenue increased by 22.94 % Company accomplished below the average Pre-Tax Profit Margin with 182.11 %.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Pre-Tax Profit Margin. While Pre-Tax Profit Margin overall ranking has deteriorated compare to previous quarter from to 27.

RVNC's Pre-Tax Profit Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 5
Healthcare Sector # 7
Overall # 27

Pre-Tax Profit Margin Statistics
High Average Low
19654.51 % 5671.42 % 182.11 %
(Dec 31 2018)   (Dec 31 2023)




Other Pre-Tax Profit Margin Profitability Ratios
RVNC's Cumulative Pre-Tax Profit Margin
Major Pharmaceutical Preparations Industry Pre-Tax Profit Margin Trends and Statistics
Healthcare Sector Pre-Tax Profit Margin Statistics
Pre-Tax Profit Margin Profitability Trends for overall market
RVNC's Pre-Tax Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Pre-Tax Profit Margin
Lowest Ranking Pre-Tax Profit Margin
Pre-Tax Profit Margin Profit Margin for RVNC's Competitors
Pre-Tax Profit Margin Profit Margin for Revance Therapeutics Inc 's Suppliers
Pre-Tax Profit Margin Profit Margin for RVNC's Customers

You may also want to know
RVNC's Annual Growth Rates RVNC's Profitability Ratios RVNC's Asset Turnover Ratio RVNC's Dividend Growth
RVNC's Roe RVNC's Valuation Ratios RVNC's Financial Strength Ratios RVNC's Pre-Tax Income Growth
RVNC's Roa RVNC's Inventory Turnover Ratio RVNC's Growth Rates RVNC's Dividend Comparisons


Companies with similar Pre-Tax Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Pre-Tax Profit MarginDec 31 2023 MRQ Pre-Tax IncomeDec 31 2023 MRQ Revenue
Revance Therapeutics Inc   182.11 %$ 127.111 $ 69.799 
Royalty Pharma Plc  120.39 %$ 717.586 $ 596.068 
Siga Technologies Inc  79.73 %$ 92.868 $ 116.481 
Prestige Consumer Healthcare Inc   49.35 %$ 139.150 $ 281.938 
United Therapeutics Corporation  48.06 %$ 295.400 $ 614.700 
Vertex Pharmaceuticals Inc  45.58 %$ 1,147.600 $ 2,517.700 
Protagonist Therapeutics inc   45.56 %$ 27.335 $ 60.000 
Catalyst Pharmaceuticals Inc   42.24 %$ 46.707 $ 110.568 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com